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FINE NEEDLE ASPIRATION CYTOLOGY OF THYROID NODULE: 
DIAGNOSTIC ACCURACY AND PITFALLS 
Saeed A. Mahar, Akhtar Husain*, Najmul Islam 
Department of Medicine, *Department of Pathology, Aga Khan University Hospital, Karachi-Pakistan 
Objective : To evaluate the utility of FNAC in patients with Thyroid Nodule. Methods : Records 
of all patients treated surgically for thyroid nodule(s) at Aga Khan University Hospital from 
January 2000 to December 2004 were reviewed. The patients who had pre operative FNAC as first 
line of the evaluation and the final post operative histopathology report available were included in 
the study. Results: 125 patients (90 female 35 male) had thyroid surgery. The cytological 
diagnosis was made according to following categories: Benign, Follicular lesion, Malignant and 
Inadequate sampling. Among 63 “Benign cases”, 57 were benign and 6 turned out to be 
malignant. Among 44 cases from “Follicular group”, 31 were benign and 13 were malignant. Out 
of 15 patients from “Malignant” group, 14 were malignant and 1 was benign. Among three 
patients from the “Inadequate sampling group”, 2 turned out to be benign and one was malignant. 
The overall results showed a sensitivity of 98%, specificity of 70%, and positive predictive value 
of 91%, negative predictive value of 93% and diagnostic accuracy of 91%. Conclusion: We 
conclude that FNAC is an invaluable and minimally invasive procedure for pre operative 
assessment of patients with a thyroid nodule in our setting as well. FNAC has high sensitivity in 
picking up malignancy in thyroid and also has high diagnostic accuracy in the evaluation of 
thyroid nodules. 
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INTRODUCTION 
Thyroid nodules are common clinical findings and 
have a reported prevalence of 4% to 7% of the adult  
population1-3, however fewer than 5% of adult 
thyroid nodules are malignant4. Thyroid nodules are 
more common in women, and the incidence increases 
with age, a history of radiation exposure and a diet 
containing goitrogenic material3. The vast majority of 
these nodules are non neoplastic lesions or benign 
neoplasms . It is preferred to operate only on those 
patients with suspicion of cancer, there by avoiding   
unnecessary surgery and possible injury of the 
recurrent laryngeal nerve, hypoparathyroidism and 
thyroid hormone dependence in patients with benign 
thyroid nodule. However, the distinction of these 
benign lesions from a malignant nodule cannot be 
based reliably on the clinical presentation alone. 
Several diagnostic tests such as scintigraphy (with123I 
or 99mTC pertechnetate), transcutaneous 
ultrasonography and fine needle aspiration cytology 
(FNA C) have been used to differentiate benign from 
malignant thyroid nodules pre operatively. FNAC has 
now supplanted most other tests for pre-operative 
evaluation of thyroid nodules.5-7 
Due to its simplicity, low cost and absence 
of major complications, this procedure is being 
performed on an increasing number of patients, 
which has led to the detection of thyroid cancers at 
earlier stages, resulting in better outcome of patients. 
Practice guidelines set forth by the American thyroid 
Association & National Comprehensive Cancer 
Network state that FNA should be used as the initial 
diagnostic test because of its superior diagnostic 
reliability and cost effectiveness before both thyroid 
scintigraphy and ultrasonography.8 Nevertheless, like 
any other test FNAC has its limitations. The reported 
pitfalls are those related to specimen adequacy, 
sampling techniques , the skill of the physician 
performing the aspiration, the experience of the 
pathologist interpreting the aspirate and overlapping 
cytological features between benign and malignant 
follicular neoplasm9-11. 
In this study, we reviewed the cytological diagnosis 
of 125 FNA C of the thyroid focusing on the 
correlation with histological diagnosis. 
PATIENTS AND METHODS 
Patient Selection 
Medical records were reviewed for all patients who 
had FNAC of a solitary or dominant thyroid 
nodule(s) during the last 5 years period between 
January 2000 to December 2004 and who 
subsequently underwent thyroid resection at Aga 
Khan University Hospital. The cytology reports were 
compared with the histogical diagnosis. 
Cytological Diagnosis  
The cytology results were categorized into 4 groups 
benign, follicular lesion (either a follicular adenoma 
or follicular carcinoma which cannot be 
differentiated on FNAC), malignant and inadequate 
(unsatisfactory) sampling. Aspirates classified as 
“benign” included adenomatous (Colloid) nodule, 
Hashimoto thyroiditis and sub acute thyroiditis. The 
“follicular” category included follicular neoplasm 
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and Hurthle cell tumo r and aspirates with atypical 
features suggestive of, but not diagnostic for 
malignancy. The aspirates with unequivocal 
cytological findings of primary or secondary 
malignancy were classified in the “malignant” 
category. Aspirates with insufficient cellularity or 
poor quality smear due to delayed or inadequate 
fixation were considered “unsatisfactory”. This group 
also included the aspirates consisting only of cyst 
fluid. 
Comparison with Final Histology 
Thyroid FNAC results, grouped malignant (positive 
results) versus the rest of diagnoses (negative results) 
were compared to the results of final histological 
study of the excised specimen in order to calculate to 
values of the test. 
Unsatisfactory aspirates and follicular lesion 
group gives no definite information, they were 
excluded from the calculation. 
a) True positive (TP): positive result in the FNA  for 
malignancy and confirmed in the histological 
study. 
b) False positive (FP): positive result in the FNA 
for malignancy but not confirmed in the 
histological study. 
c) True negative (TN): negative result in the FNA 
for malignancy and no carcinoma in the 
histological study. 
d) False negative (FN): negative result in the FNA 
for malignancy but with a carcinoma in the 
histological study. 
e) Sensitivity (S): proportion of patients with 
associated carcinoma and a positive result in the 
FNA for malignancy, S = TP/(TP+FN) 
f) Specificity (Sp): proportion of patients without 
associated carcinoma and with a negative results 
in the FNA for malignancy SP = TN (TN+FP).  
g) Positive predictive value(PPV): proportion of 
patients with a positive results and his tological 
confirmation PPV = TP(TP + FP) 
h) Negative Predictive value (NPV): proportion of 
patients with negative results and without a 
carcinoma in the histological study. NPV = 
TN(TN+FN) 
i) Diagnostic accuracy (DA) proportion of patients 
diagnosed correctly by the diagnostic test, DA = 
(TP + TN) / (FP + FN + TP + TN) 
Sensitivity, specificity, positive predictive 
value, negative predictive value and accuracy of 
FNA C relative to final histological diagnosis were 
analyzed by SPSS software . 
RESULTS  
We included 125 patients who under went FNAC 
followed by Thyroidectomy  (lobectomy or total 
thyroidectomy) for a thyroid nodule. The 90(72%) 
female and 35(28%) male patients had a median age 
of 39 years (range 13 to 76) at the time of 
Thyroidectomy . 
The FNA cytology results were compared 
with the corresponding histological diagnosis. The 
FNA C results were interpreted as benign in 
63(50.4%), follicula r 44(35.2%), malignant 15(12%) 
and unsatisfactory in 3 (2.4%). (Table 1) 
Table-1: Diagnosis in the 125 Thyroid Nodules 
with FNAC 
 Frequency Valid Percent 
Benign 63 50.4 
Follicular 44 35.2 
Malignant 15 12.0 
Inadequate sampling 3 2.4 
Total 125 100.0 
The histological findings for 63 patients 
with a cytological diagnosis of benign, 57 were 
benign and 6 had malignant diagnosis. Of 44 cases 
with cytological diagnosis of follicular neoplasm, 31 
had benign and 13 had malignant diagnosis on final 
histology. Among 15 patients with cytological 
diagnosis of malignant lesion, final histopathology 
revealed 1 case as benign. We had 3 patients in 
unsatisfactory group 2 were benign and 1 was 
malignant on final histopathology. (Table 2) 
Table-2: Correlation between FNAC and final 
histology 
HISTOPATHOLOGY 
  Benign Malignant Total 
Benign 57 6 63 
Follicular  31 13 44 
Malignant 1 14 15 
Inadequate sampling 2 1 3 
F
N
A
C 
Total 91 34 125 
Table-3: Distribution of Malignant Cases (n-34) 
 Frequency Percentage 
Papillary Ca 18 52.94 
Follicular Ca 8 23.52 
Medullary 6 17.64 
Anaplastic 2 5.9 
Total 34 100 
We identified one false positive result from 
malignant group and 6 false negative results came 
from benign group.  
Analysis of the FNAC results obtained were 
compared with the histological findings in order to 
rule out malignancy yielded a sensitivity (95% CI) of 
98% (92.3% – 99%) specificity (95% CI) of 70%  
(53% – 75%) with positive predictive value of 91% 
and negative predictive value of 93% with diagnostic 
accuracy of 91% . 
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DISCUSSION  
FNAC contributes significantly to the pre operative 
investigation in patients with a solitary or dominant 
thyroid nodule but despite its well recognized value 
there are limitations to the technique.  
The aim of this study was to evaluate the diagnostic 
accuracy in 125 patients with thyroid nodules 
submitted to FNAC and afterwards to surgery. 
The false negative FNAC results may occur 
because of sampling error or misinterpretation of 
cytology, and are of great concern because they 
indicate the potential to miss malignant lesion.12 
However, it is difficult to calculate the true frequency 
of false negative results because only a small 
percentage (approx 10%) of patients with benign 
cytological findings under go surgery.13 Most 
authorities agree that the true false negative rate is 
below 5% if all patients with thyroid FNA C also have 
a histological examination.13  
False negative FNA cytology results occurred in 
6(3.78%) of our patients. This is also consistent with 
recent reports in the literature that suggest a false 
negative rate of 2% to 7%14-19 and other reported 
range from 1% to 16% in different series.2,9,11 
A false positive cytology result may in 
retrospect have resulted in surgical over treatment for 
an individual patient. False positive FNA cytology 
results are uncommon and were found in only 
1(0.15%) patient in this series. This finding is 
consistent with other recent reports that cited an 
incidence of false positive FNA cytology results 
ranging from 0% to 9%.14-19 
We categorized cytological results into 
Benign, Follicular, Malignant and Indeterminate. 
Such categorization of FNA cytology results is 
necessary to allow clinicians to use cytology results 
to guide patient management with specific reference 
to the need for Thyroidectomy . 
In the follicular group 13(5.72%) were malignant, 
which was due to limitations of thyroid cytology to 
distinguish follicular adenoma from follicular 
carcinoma.20-23 This diagnosis require detailed 
histological examination for vascular and capsular 
invasion and cannot be reliably made on routine 
FNAC specimens.24-28  
The sensitivity of thyroid FNAC ranges 
from 65% to 99% and its specificity from 72% to 
100%. 29-32 In this study, the sensitivity for 
cytological diagnosis of neoplasia was 98%, 
specificity of 70%, positive predictive value of 91%, 
negative predictive value of 93% and diagnostic 
accuracy of 91% which is similar to the experience of 
others.24,25,33. Ikram et al has reported sensitivity and 
specificity for malignancy as 100% which is slightly 
higher then our results as they do not have false 
positive results in their study due to small number of 
patients.34 Our study also testifies the results of 
previously done study at Aga Khan University by 
Afroze N et al, where they have reported sensitivity 
of 61.9%, the specificity of 99.31%, positive 
predictive value 92.86%, negative predictive value of 
94.74% and accuracy index of 94.58% . This is 
slightly different then our results  and this may be due 
to the fact that they had considered suspicious cases 
alternatively as positives and negatives.35 Our results 
also coincides with results of Safirullah et al, where 
they have reported a sensitivity of  94.2%.36 
Inadequate FNA specimen may be results of 
inadequate sampling or focal lesion. Thyroid nodules 
that are sclerotic or calcified and those with large 
areas of cystic degeneration or necrosis are extremely 
difficult to aspirate. In our series 3(2.4%) patients 
have inadequate sampling which again corresponds 
to results of international studies in which the 
inadequate sampling has been reported from     1 % 
to 5 %4. The advent of ultrasound guided FNA biopsy 
improved specimen acquisition, especially in patients 
with small thyroid nodules or nodule that are difficult 
or impossible to detect on physical examination36-38.  
CONCLUSION 
The assessment of the patient with a thyroid 
nodule(s) includes the triple modalities of clinical 
examination, cytology and imaging investigations. 
The result of thyroid aspiration cytology is  therefore 
only one factor governing the management decision. 
Indeterminate FNAC results and cytodiagnostic 
errors are unavoidable due to overlapping cytological 
features particularly among hyperplastic adenomatoid 
nodules , follicular neoplasms and follicular variants 
of papillary carcinomas.  
Ongoing correlation of cytology and 
histology is an important quality assurance measure 
and it allows laboratories to calculate their false 
positive and false negative rates.  
We conclude that FNAC is an invaluable and 
minimally invasive procedure for pre operative 
assessment of patients with a thyroid nodule. FNAC 
has high accuracy in the diagnostic evaluation of 
thyroid nodule.    
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